These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17978127

  • 21. [Analysis of risk factors for adverse perinatal outcomes in women with pancytopenia].
    Wang X, Zhang C, Liang M, Zhang X, Wang J, Zhang X.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):931-6. PubMed ID: 26887878
    [Abstract] [Full Text] [Related]

  • 22. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
    Reddy M, Fenn S, Rolnik DL, Mol BW, da Silva Costa F, Wallace EM, Palmer KR.
    Am J Obstet Gynecol; 2021 Feb; 224(2):217.e1-217.e11. PubMed ID: 32795430
    [Abstract] [Full Text] [Related]

  • 23. Blood typing profile of a school-aged population of a North Togo township.
    Vovor A, Fétéké L, Kueviakoe IM, Kpatarou L, Mawussi K, Magnang H, Ségbéna AY.
    Hemoglobin; 2014 Feb; 38(5):316-8. PubMed ID: 25271992
    [Abstract] [Full Text] [Related]

  • 24. The Risk of Pregnancy Related Hypertension Disorder Associated with Sickle Cell Trait in U.S. Service Women.
    O'Hara C, Singer DE, Niebuhr DW.
    Mil Med; 2020 Feb 12; 185(1-2):e183-e190. PubMed ID: 31247087
    [Abstract] [Full Text] [Related]

  • 25. Hemoglobin S and C traits: contributing causes for decreased mean hematocrit in African-American children.
    Rana SR, Sekhsaria S, Castro OL.
    Pediatrics; 1993 Apr 12; 91(4):800-2. PubMed ID: 8464670
    [Abstract] [Full Text] [Related]

  • 26. Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort.
    Lewis G, Thame M, Howitt C, Hambleton I, Serjeant GR.
    BJOG; 2021 Sep 12; 128(10):1703-1710. PubMed ID: 33683802
    [Abstract] [Full Text] [Related]

  • 27. Maternal and perinatal outcomes amongst haemoglobinopathy carriers: a systematic review.
    Jans SM, de Jonge A, Lagro-Janssen AL.
    Int J Clin Pract; 2010 Nov 12; 64(12):1688-98. PubMed ID: 20946275
    [Abstract] [Full Text] [Related]

  • 28. Maternal hemoglobin concentration and adverse pregnancy outcomes at low and moderate altitudes in Peru.
    Gonzales GF, Tapia V, Gasco M, Carrillo CE.
    J Matern Fetal Neonatal Med; 2012 Jul 12; 25(7):1105-10. PubMed ID: 22004716
    [Abstract] [Full Text] [Related]

  • 29. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusions.
    Cunningham FG, Pritchard JA, Mason R.
    Obstet Gynecol; 1983 Oct 12; 62(4):419-24. PubMed ID: 6888818
    [Abstract] [Full Text] [Related]

  • 30. The obstetric performance of sickle cell disease patients and homozygous hemoglobin C disease patients in Ile-Ife, Nigeria.
    Dare FO, Makinde OO, Faasuba OB.
    Int J Gynaecol Obstet; 1992 Mar 12; 37(3):163-8. PubMed ID: 1351002
    [Abstract] [Full Text] [Related]

  • 31. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK, Akinyanju O.
    West Afr J Med; 1993 Mar 12; 12(2):96-100. PubMed ID: 8398940
    [Abstract] [Full Text] [Related]

  • 32. [Maternal and perinatal outcomes in pregnancies complicated by sickle cell diseases].
    Nomura RM, Igai AM, Tosta K, da Fonseca GH, Gualandro SF, Zugaib M.
    Rev Bras Ginecol Obstet; 2010 Aug 12; 32(8):405-11. PubMed ID: 21180878
    [Abstract] [Full Text] [Related]

  • 33. Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth.
    Serjeant GR, Hambleton I, Thame M.
    BJOG; 2005 Sep 12; 112(9):1308-14. PubMed ID: 16101613
    [Abstract] [Full Text] [Related]

  • 34. Impact of high maternal hemoglobin at first antenatal visit on pregnancy outcomes: a cohort study.
    Phaloprakarn C, Tangjitgamol S.
    J Perinat Med; 2008 Sep 12; 36(2):115-9. PubMed ID: 18331205
    [Abstract] [Full Text] [Related]

  • 35. Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes.
    Figueira CO, Guida JPS, Surita FG, Antolini-Tavares A, Saad ST, Costa FF, Fertrin KY, Costa ML.
    Hematol Transfus Cell Ther; 2024 Nov 12; 46 Suppl 5():S189-S196. PubMed ID: 38494406
    [Abstract] [Full Text] [Related]

  • 36. Sickle cell trait in pregnancy.
    Miller JM.
    South Med J; 1983 Aug 12; 76(8):962-3, 965. PubMed ID: 6879289
    [Abstract] [Full Text] [Related]

  • 37. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome.
    Howard RJ, Tuck SM, Pearson TC.
    Br J Obstet Gynaecol; 1995 Dec 12; 102(12):947-51. PubMed ID: 8652484
    [Abstract] [Full Text] [Related]

  • 38. Pregnancy loss after first trimester viability in women with sickle cell trait: a preliminary report.
    Taylor MY, Wyatt-Ashmead J, Gray J, Bofill JA, Martin RW, Morrison JC.
    South Med J; 2008 Feb 12; 101(2):150-1. PubMed ID: 18364614
    [Abstract] [Full Text] [Related]

  • 39. Presence of the sickle cell trait and preterm delivery in African-American women.
    Bryant AS, Cheng YW, Lyell DJ, Laros RK, Caughey AB.
    Obstet Gynecol; 2007 Apr 12; 109(4):870-4. PubMed ID: 17400848
    [Abstract] [Full Text] [Related]

  • 40. Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study.
    Afolabi BB, Iwuala NC, Iwuala IC, Ogedengbe OK.
    J Obstet Gynaecol; 2009 Feb 12; 29(2):104-6. PubMed ID: 19274540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.